Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VALEANT PHARMACEUTICALS INTL Key Ratios

  • Valuation Ratio: VRX

    P/E (TTM) -10.55
    Price to CashFlow 14.68
    Price to Sales (TTM) 3.05
    Price to Book 6.76
  • Per Share Ratio: VRX

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 3.69
    EPS Fully Diluted -2.17
    Revenue Per Share 7.51
  • 5 Year Annual Growth: VRX

    Net Income
    Revenue -0.86%
    Dividend Per Share (TTM) -100.00%
    EPS -22.48%
  • Dividends: VRX

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.80%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: VRX

    Operations Margin 11.28%
    Net Profit Margin -3.61%
    Gross Profit Margin 66.83%
  • Financial Strength: VRX

    Quick Ratio (MRQ) 1.24
    Current Ratio (MRQ) 1.58
    LT Debt to Equity (MRQ) 163.68
    Total Debt to Equity (MRQ) 177.96
    Return on Equity (ROE) Per Share -60.90
    Return on Assets (ROA) -3.23
    Return on Invested Capital (ROIC) -0.42
  • Assets: VRX

    Asset Turnover 0.56
    Inventory Turnover 1.98